Results 1 to 10 of about 82,737 (314)
Frontiers in Endocrinology, 2023 ObjectiveTo assess whether the administration of Zishen Yutai Pill (ZYP) could improve the pregnancy outcomes in different subgroups of women undergoing fresh embryo transfer cycles.Materials and methodsThis is a post hoc analysis of a large scale ...
Xiaoli Chen +7 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Chinese herbal medicines offer a rich source of anti-cancer drugs. Differences between the pharmacology of Chinese herbal medicines and modern synthetic chemicals hinder the development of drugs derived from herbal products.
Si-Yi Li +13 more
doaj +1 more source
Pharmaceuticals, 2023 The application of chemotherapy drugs in tumor treatment has a long history, but the lack of selectivity of drugs often leads to serious side effects during chemotherapy.
Hongrui Zhou +6 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Background: Chronic kidney disease (CKD) is a leading cause of morbidity and mortality. Mitochondrial dysfunction has been implicated as a key factor in the development of CKD.
Jiayi Tian +12 more
doaj +1 more source
Chinese herbal drugs for the treatment of diabetic retinopathy [PDF]
Journal of Pharmacy and Pharmacology, 2017 AbstractObjectivesTo explore the various pharmacological actions and the molecular mechanisms behind them by which Chinese herbs tend to lower the risk of developing microvascular diabetic complications in retina and prevent its further progression.Key findingsSeveral Chinese herbs, indeed, elicit potent anti-inflammatory, antioxidant, anti-angiogenic,
Tapan, Behl, Anita, Kotwani
openaire +2 more sources
Chinese herbal therapy and Western drug use, belief and adherence for hypertension management in the rural areas of Heilongjiang province, China. [PDF]
PLoS ONE, 2015 Traditional Chinese medicine (TCM) including Chinese herbal therapy has been widely practiced in China. However, little is known about Chinese herbal therapy use for hypertension management, which is one of the most prevalent chronic conditions in China.
Xia Li +9 more
doaj +1 more source
Mitochondrial DNA. Part B. Resources, 2021 The relationship between Callicarpa rubella Lindl. and its infraspecific taxa has troubled researchers for a long time. Here, we reported for the first time the complete chloroplast (cp) genome of C.
Huimin Cai +3 more
doaj +1 more source
Pharmacological Research, 2023 Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality, imposing an increasing global health burden. Cardiac ion channels (voltage-gated NaV, CaV, KVs, and others) synergistically shape the cardiac action potential (AP) and ...
Zhenzhen Yan +4 more
doaj +1 more source
Key quality factors for Chinese herbal medicines entering the EU market
Chinese Medicine, 2022 Chinese herbal medicines (CHMs) have unique advantages in the prevention and treatment of diseases, which are widely recognized in the world. More and more CHMs are becoming increasingly popular in the international markets.
Mei Wang +4 more
doaj +1 more source
The impact of herbal medicine in regulating intestinal flora on female reproductive disorders
Frontiers in Pharmacology, 2022 As an important part of the human intestinal microecology, the intestinal flora is involved in a number of physiological functions of the host. Several studies have shown that imbalance of intestinal flora and its regulation of the intestinal barrier ...
Min Liu +5 more
doaj +1 more source